BioSpace News Archive

Verismo Therapeutics today announced it has raised $17M in a second pre-Series A financing round.

NorthStar Medical Radioisotopes today announced the signing of a supply agreement for the therapeutic medical radioisotope, actinium-225 (Ac-225) with Bayer.

ChromaDex Corp. announced promising findings from two independent clinical study abstracts originally presented this past April at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting.

Genprex, Inc. today announced it has entered into an exclusive license agreement with the University of Pittsburgh.

Celularity Inc., a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, announced that it will present data on its proprietary extracellular matrices at ICBST23, the International Conference on Biomaterials Science and Tissue Engineering, to be held on 24-26 July in Osaka, Japan.

Ceapro Inc. announced today the expansion of its collaboration with the Angiogenesis Foundation to conduct research on characterizing healing dynamics and molecular profiling of tissue regeneration stimulated by oat-derived bioactives.

In a significant milestone for the Allen Institute for Immunology, a division of the Allen Institute, researchers and staff will collaborate with private industry researchers to aid in the detailed, molecular understanding of disease, in service of developing new treatments and therapies to improve human health.

Pharming Group N.V. announces that the Board of Directors has nominated Dr. Richard Peters to become Pharming’s new Chairman.

POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis and rare metabolic disorders, announced its participation at the upcoming H.C.

LEX Diagnostics announces the appointment of Dr Heather Danks as its Chief Technology Officer.